[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES495036A0 - Un procedimiento para la produccion de analogos de cefalosporina. - Google Patents

Un procedimiento para la produccion de analogos de cefalosporina.

Info

Publication number
ES495036A0
ES495036A0 ES495036A ES495036A ES495036A0 ES 495036 A0 ES495036 A0 ES 495036A0 ES 495036 A ES495036 A ES 495036A ES 495036 A ES495036 A ES 495036A ES 495036 A0 ES495036 A0 ES 495036A0
Authority
ES
Spain
Prior art keywords
procedure
production
cephalosporin analogs
cephalosporin
analogs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES495036A
Other languages
English (en)
Other versions
ES8200142A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP13698679A external-priority patent/JPS5661377A/ja
Priority claimed from JP5561880A external-priority patent/JPS56152478A/ja
Priority claimed from JP10242280A external-priority patent/JPS5729291A/ja
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Publication of ES8200142A1 publication Critical patent/ES8200142A1/es
Publication of ES495036A0 publication Critical patent/ES495036A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/78Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D463/00Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/02Preparation
    • C07D463/06Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D463/00Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • C12P17/184Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system containing a beta-lactam ring, e.g. thienamycin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cephalosporin Compounds (AREA)
ES495036A 1979-10-25 1980-09-12 Un procedimiento para la produccion de analogos de cefalosporina. Granted ES495036A0 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP13698679A JPS5661377A (en) 1979-10-25 1979-10-25 Optically active cephaloasporin analog
JP5561880A JPS56152478A (en) 1980-04-26 1980-04-26 Optically active cephalosporin analog
JP10242280A JPS5729291A (en) 1980-07-28 1980-07-28 Preparation of optically active cephalosporin analoge

Publications (2)

Publication Number Publication Date
ES8200142A1 ES8200142A1 (es) 1981-10-16
ES495036A0 true ES495036A0 (es) 1981-10-16

Family

ID=27295649

Family Applications (1)

Application Number Title Priority Date Filing Date
ES495036A Granted ES495036A0 (es) 1979-10-25 1980-09-12 Un procedimiento para la produccion de analogos de cefalosporina.

Country Status (7)

Country Link
EP (1) EP0027882B1 (es)
AU (1) AU6235580A (es)
CA (1) CA1160584A (es)
DE (1) DE3069901D1 (es)
DK (1) DK389180A (es)
ES (1) ES495036A0 (es)
NO (1) NO802714L (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0082501A1 (en) * 1981-12-18 1983-06-29 Kyowa Hakko Kogyo Co., Ltd Beta-lactam compound and a pharmaceutical composition containing the same
DE3803169A1 (de) 1988-02-03 1989-08-17 Bayer Ag Ss-lactam-antibiotika, verfahren zu ihrer herstellung und ihre verwendung als und in arzneimitteln
US5099015A (en) * 1991-01-10 1992-03-24 Eli Lilly And Company Trifluoromethyl 1-carba(1-dethia)cephems

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7902598L (sv) * 1978-03-25 1979-10-04 Kyowa Hakko Kogyo Kk Cephalosporinanaloger

Also Published As

Publication number Publication date
NO802714L (no) 1981-04-27
CA1160584A (en) 1984-01-17
DE3069901D1 (en) 1985-02-14
EP0027882A1 (en) 1981-05-06
ES8200142A1 (es) 1981-10-16
EP0027882B1 (en) 1985-01-02
AU6235580A (en) 1982-07-29
DK389180A (da) 1981-04-26

Similar Documents

Publication Publication Date Title
ES492053A0 (es) Un procedimiento para la produccion de un plasmido.
ES505760A0 (es) Un procedimiento para la produccion de nuevas cefalosporinas.
ES495559A0 (es) Un procedimiento para la produccion de microcapsulas
ES518667A0 (es) Un procedimiento para la produccion de un derivado de carbostirilo.
ES514994A0 (es) Un procedimiento para la preparacion de nuevos derivados de cefalosporina.
ES490645A0 (es) Un procedimiento para la produccion de un derivado 4-amino- 3-carboxi o ciano-1,2-dihidro-2-oxo-1,8-naftiridina
ES487833A0 (es) Procedimiento para la produccion de un preparado farmaceuti-co
ES503502A0 (es) Un procedimiento para la produccion de un derivado de pripe-razina.
ES499401A0 (es) Un procedimiento para la produccion de compuestos de tria- ril-metano
ES500056A0 (es) Un procedimiento de preparacion de compuestos intermedios para la produccion de picropodofilina.
ES488209A0 (es) Un procedimiento para la produccion de un derivado de antra-ciclina
ES497525A0 (es) Un procedimiento para la produccion de derivados de halogeno-triacinilo.
ES497366A0 (es) Un procedimiento para la preparacion de nuevos compuestos de mercaptoorganosiloxano.
ES493846A0 (es) Un procedimiento para la preparacion de nuevos compuestos oligolipidos.
ES496980A0 (es) Un procedimiento para la produccion de un derivado de benza-mida
ES492443A0 (es) Un procedimiento para la produccion de cefamicina c.
ES486463A0 (es) Un procedimiento para la produccion de cefalosporinas.
ES495035A0 (es) Un procedimiento para la produccion de analogos de cefalosporina.
ES488848A0 (es) Un procedimiento para la preparacion de un antibiotico de cefalosporina.
ES495137A0 (es) Un procedimiento para la preparacion de derivados de cefalosporina.
ES530212A0 (es) Un procedimiento para la produccion de un derivado de 2-amino-tiazol.
ES495036A0 (es) Un procedimiento para la produccion de analogos de cefalosporina.
ES501220A0 (es) Un procedimiento para la produccion de nuevas isoxolil-indolaminas.
ES493350A0 (es) Un procedimiento para la produccion de derivados de talisomicina.
ES505550A0 (es) Un procedimiento para la preparacion de cefalosporina bis-tetrazolmetil sustituidas.